Home > Boards > US Listed > Biotechs > Ionis Pharmaceuticals Inc. (IONS)

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Stochastic Analysis

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
HERMES8 Member Profile
 
Followed By 2
Posts 42
Boards Moderated 0
Alias Born 09/09/17
160x600 placeholder
Ionis to hold virtual investor day event PR Newswire (US) - 12/2/2021 3:03:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/26/2021 4:06:34 PM
Ionis Reveals Results study of vupanorsen TipRanks - 11/26/2021 8:16:12 AM
Ionis Pharmaceuticals (IONS) Gets a Hold Rating from Leerink Partners TipRanks - 11/25/2021 4:10:12 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2021 9:30:11 AM
Ionis Pharma: Clinical Study of Vupanorsen Meets Primary Endpoint Dow Jones News - 11/24/2021 7:29:00 AM
Ionis says that Pfizer reports topline results from Phase 2b vupanorsen study Seeking Alpha - 11/24/2021 7:20:53 AM
Ionis announces that Pfizer reports topline results from Phase 2b clinical study of vupanorsen PR Newswire (US) - 11/24/2021 6:30:00 AM
Ionis initiates Phase 3 clinical program of donidalorsen in patients with hereditary angioedema PR Newswire (US) - 11/18/2021 1:30:00 PM
Ionis' antisense therapies to be featured at the American Heart Association (AHA) Scientific Sessions 2021 PR Newswire (US) - 11/12/2021 7:05:00 AM
Ionis to present at upcoming virtual investor conferences PR Newswire (US) - 11/9/2021 7:05:00 AM
Phase 2 study results of Ionis' novel antisense treatment for hereditary angioedema to be presented at ACAAI annual meeting PR Newswire (US) - 11/7/2021 7:05:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/3/2021 3:38:31 PM
Ionis sees Q3 net loss more than double due to restructured operations, R&D costs Seeking Alpha - 11/3/2021 8:54:21 AM
Ionis Pharmaceuticals EPS misses by $0.05, misses on revenue Seeking Alpha - 11/3/2021 7:05:19 AM
Ionis reports third quarter 2021 financial results and recent business achievements PR Newswire (US) - 11/3/2021 7:00:00 AM
Ionis Pharmaceuticals Q3 2021 Earnings Preview Seeking Alpha - 11/2/2021 11:33:15 AM
Ionis initiates late-stage olezarsen hypertriglyceridemia study Seeking Alpha - 11/2/2021 7:16:21 AM
Ionis initiates pivotal Phase 3 clinical study of olezarsen in patients with severe hypertriglyceridemia PR Newswire (US) - 11/2/2021 7:05:00 AM
Ionis to hold third quarter 2021 financial results webcast PR Newswire (US) - 10/20/2021 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2021 6:30:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2021 6:30:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2021 6:29:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2021 2:31:51 PM
Ionis Pharma Shares Drop 12% After Tofersen Study Misses Primary Endpoint Dow Jones News - 10/18/2021 10:55:00 AM
HERMES8   Friday, 10/13/17 03:32:42 PM
Re: None
Post # of 485 
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Stochastic Analysis

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) for the period of 9-Day stands at 91.68% while the stochastic %D for the same period stands at 90.12%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) while 20-100 Day MACD Oscillator
“Buy”.

http://www.stocksmarketnews.com/ionis-pharmaceuticals-inc-nasdaqions-stochastic-analysis/

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences